Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed...
SYDNEY, March 31, 2020 /PRNewswire-Asianet/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O'Bryan-Tear will be chairing Clarity's newly formed Global Clinical Development group.Dr O'Bryan-Tear j...
Authors: LATEST ASIANET NEWS RELEASES